The role of rotational thromboelastometry in assessment of haemostasis during pregnancy in women with factor XI deficiency

Haemophilia

Volumn 22, Issue 2, 2016, Pages 276-284

  Davies, J ^a   Harper, A ^a   Kadir, R A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Blood products; Factor XI; Haemostasis; Inherited coagulation disorders; Pregnancy

Indexed keywords

ADULT; ANALYZER; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING TIME; CLOT FORMATION TIME; CONTROLLED STUDY; DELIVERY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MATERNAL CARE; MAXIMUM CLOT FIRMNESS; PREGNANCY OUTCOME; PREGNANT WOMAN; PRIORITY JOURNAL; RISK ASSESSMENT; ROTATIONAL THROMBOELASTOMETRY; YOUNG ADULT;

EID: 84960130143     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12807     Document Type: Article

References (28)

1. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-82.
2. Clark P. Changes of hemostasis variables during pregnancy. Semin Vasc Med 2003; 3: 13-24.
3. Kadir RA, Lee CA, Sabin CA, Pollard D, Economides DL. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol 1998; 105: 314-21.
4. Chi C, Kulkarni A, Lee CA, Kadir RA. The obstetric experience of women with factor XI deficiency. Acta Obstet Gynecol Scand 2009; 88: 1095-100.
5. Myers B, Pavord S, Kean L, Hill M, Dolan G. Pregnancy outcome in factor XI deficiency: incidence of miscarriage, antenatal and postnatal haemorrhage in 33 women with factor XI deficiency. BJOG 2007; 114: 643-6.
6. Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10: 615-21.
7. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinolysis 2005; 16: 37-41.
8. Hoffman C, Hultin MB. Factor IX concentrate therapy and thrombosis: relation to changes in plasma antithrombin III. Thromb Res 1986; 43: 143-51.
9. Bolton-Maggs PH, Colvin BT, Satchi BT, Lee CA, Lucas GS. Thrombogenic potential of factor XI concentrate. Lancet 1994; 344: 748-9.
10. Kenet G, Lubetsky A, Luboshitz J, Ravid B, Tamarin I, Varon D, et al. Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors. Haemophilia 2009; 15: 1065-73.
11. Livnat T, Tamarin I, Mor Y, Winckler H, Horowitz Z, Korianski Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost 2009; 102: 487-92.
12. Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost 2011; 106: 521-7.
13. Barrowcliffe TW, Cattaneo M, Podda GM, Bucciarelli P, Lussana F, Lecchi A, et al. New approaches for measuring coagulation. Haemophilia 2006; 12(Suppl 3): 76-81.
14. van Rheenen-Flach LE, Zweegman S, Boersma F, Lenglet JE, Twisk JW, Bolte AC. A prospective longitudinal study on rotation thromboelastometry in women with uncomplicated pregnancies and postpartum. Aust N Z J Obstet Gynaecol 2013; 53: 32-6.
15. Tola G, Sirparo S, Ruggeri L, Capogna G. Thromboelastometry during labor and after delivery. Open J Anesthesiol 2013; 03: 218-23.
16. Huissoud C, Carrabin N, Benchaib M, Fontaine O, Levrat A, Massignon D, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy. Thromb Haemost 2009; 101: 755-61.
17. Armstrong S, Fernando R, Ashpole K, Simons R, Columb M. Assessment of coagulation in the obstetric population using ROTEM(R) thromboelastometry. Int J Obstet Anesth 2011; 20: 293-8.
18. Livnat T, Shenkman B, Martinowitz U, Zivelin A, Dardik R, Tamarin I, et al. The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency. Thromb Res 2015; 136: 465-73.
19. Gueguen P, Galinat H, Blouch MT, Bridey F, Duchemin J, Le Gal G, et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency. Br J Haematol 2012; 156: 245-51.
20. Zucker M, Seligsohn U, Salomon O, Wolberg AS. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 2014; 12: 1121-30.
21. Rugeri L, Quelin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia 2010; 16: 771-7.
22. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Batlle J, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
23. Salooja N, Perry DJ. Thrombelastography. Blood Coagul Fibrinolysis 2001; 12: 327-37.
24. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10.
25. Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, et al. Factor XI contributes to thrombin generation in the absence of factor XII. Blood 2009; 114: 452-8.
26. O'Connell NM. Factor XI deficiency. Semin Hematol 2004; 41: 76-81.
27. Lee CA, Chi C, Pavord SR, Bolton-Maggs PH, Pollard D, Hinchcliffe-Wood A, et al. The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006; 12: 301-36.
28. Salomon O, Steinberg DM, Zucker M, Varon D, Zivelin A, Seligsohn U. Patients with severe factor XI deficiency have a reduced incidence of deep-vein thrombosis. Thromb Haemost 2011; 105: 269-73.